Lanean...
Ruxolitinib for the Treatment of Patients With Polycythemia Vera
Polycythemia vera (PV) is a hematopoietic proliferative disorder associated with Janus-associated kinase (JAK)/signal transducer and activator of transcription (STAT) pathway dysregulation resulting in erythrocytosis and, possibly, leukocytosis and thrombocytosis. Patients diagnosed with PV experien...
Gorde:
| Argitaratua izan da: | Expert Rev Hematol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627585/ https://ncbi.nlm.nih.gov/pubmed/25980454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2015.1045869 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|